Published in Br J Surg on September 01, 1972
Neuromuscular electrostimulation viathe common peroneal nerve promotes lower limb blood flow in a below-kneecast: A potential for thromboprophylaxis. Bone Joint Res (2013) 0.87
Optimal electrical stimulus for prevention of deep vein thrombosis. Br Med J (1972) 0.86
Ankle positions and exercise intervals effect on the blood flow velocity in the common femoral vein during ankle pumping exercises. J Phys Ther Sci (2016) 0.85
Deep vein thrombosis prophylaxis in trauma patients. Thrombosis (2011) 0.85
The geko™ electro-stimulation device for venous thromboembolism prophylaxis: a NICE medical technology guidance. Appl Health Econ Health Policy (2015) 0.83
The detection of venous thrombosis of the legs using 125-I-labelled fibrinogen. Br J Surg (1968) 10.22
Natural history of postoperative deep-vein thrombosis. Lancet (1969) 5.18
125-I-labelled fibrinogen test adapted for routine screening for deep-vein thrombosis. Lancet (1970) 4.48
Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat Med (1999) 4.33
Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke (1999) 2.89
Oral contraceptives, antithrombin- III activity, and postoperative deep-vein thrombosis. Lancet (1976) 2.77
Deep vein thrombosis of the leg. Is there a "high risk" group? Am J Surg (1970) 2.66
Value of graduated compression stockings in deep venous insufficiency. Br Med J (1980) 2.65
Low doses of heparin in prevention of deep-vein thrombosis. Lancet (1971) 2.38
Testing the raters: inter-rater reliability of standardized anaesthesia simulator performance. Can J Anaesth (1997) 2.37
Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis. N Engl J Med (2001) 2.31
Efficacy of low doses of heparin in prevention of deep-vein thrombosis after major surgery. A double-blind, randomised trial. Lancet (1972) 2.20
Graduated compression stockings in the prevention of postoperative deep vein thrombosis. Br J Surg (1990) 2.14
Small doses of subcutaneous sodium heparin in preventing deep venous thrombosis after major surgery. Lancet (1972) 2.13
Postoperative deep-vein thrombosis. Effect of intensive prophylaxis. Lancet (1969) 2.09
A physiological study of elastic compression stockings in venous disorders of the leg. Br J Surg (1980) 2.06
Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes. J Biol Chem (1989) 2.05
The origin of deep vein thrombosis: a venographic study. Br J Radiol (1971) 1.96
Testing internal consistency and construct validity during evaluation of performance in a patient simulator. Anesth Analg (1998) 1.95
Management of abdominal aortic aneurysm. Br J Surg (1978) 1.95
Evaluation of non-invasive and invasive methods in the assessment of short saphenous vein termination. Br J Surg (1989) 1.91
Improving walking ability and ankle brachial pressure indices in symptomatic peripheral vascular disease with intermittent pneumatic foot compression: a prospective controlled study with one-year follow-up. J Vasc Surg (2000) 1.85
Treatment of deep vein thrombosis. A trial of heparin, streptokinase, and arvin. Br Med J (1969) 1.82
Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet (1992) 1.81
Late results of treatment of deep vein thrombosis. Br Med J (1969) 1.77
'Real' epidemiology of varicose veins and chronic venous diseases: the San Valentino Vascular Screening Project. Angiology (2002) 1.68
The origin of thrombi in the deep veins of the lower limb: a venographic study. Br J Surg (1978) 1.65
Sugar intake, serum insulin and platelet adhesiveness in men with and without peripheral vascular disease. Postgrad Med J (1969) 1.63
Cold adaptation and the seasonal distribution of acute myocardial infarction. QJM (1999) 1.62
Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood (1995) 1.59
Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence. Int Angiol (2001) 1.59
Raynaud's syndrome. BMJ (1990) 1.52
Significance of popliteal reflux in relation to ambulatory venous pressure and ulceration. Arch Surg (1979) 1.50
Femorodistal vein bypass graft stenoses. Br J Surg (1988) 1.48
Antithrombin-TRI (Ala382 to Thr) causing severe thromboembolic tendency undergoes the S-to-R transition and is associated with a plasma-inactive high-molecular-weight complex of aggregated antithrombin. Br J Haematol (1995) 1.47
Abnormal carotid arterial wall dynamics in symptom-free hypopituitary adults. Eur J Endocrinol (1997) 1.43
Carotid plaque characterization using digital image processing and its potential in future studies of carotid endarterectomy and angioplasty. J Endovasc Surg (1998) 1.43
Late-onset homozygous protein C deficiency. Lancet (1991) 1.43
Haemodynamic significance of incompetent calf perforating veins. Br J Surg (1991) 1.42
Detection and grading of femorodistal vein graft stenoses: duplex velocity measurements compared with angiography. J Vasc Surg (1988) 1.42
Lipid peroxides and atherosclerosis. BMJ (1989) 1.41
Cardiovascular, autonomic, and plasma catecholamine responses in unilateral and bilateral carotid artery stenosis. J Neurol Neurosurg Psychiatry (1999) 1.40
The effect of low molecular weight heparin on intimal hyperplasia in vein grafts. Eur J Vasc Surg (1994) 1.39
Influence of whole blood on standard curve for heparin measurement--possible heparin binding by red cells. Thromb Haemost (1989) 1.39
Lung function test findings in patients with chronic fatigue syndrome (CFS) Aust N Z J Med (1996) 1.39
Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting. Lancet (1994) 1.39
Histological analysis of the carotid plaque post-endarterectomy: a waste of time or a wasted piece of information? Eur J Vasc Endovasc Surg (2011) 1.39
Brain CT infarction in patients with carotid atheroma. Does it predict a future event? Int Angiol (2001) 1.39
Fibrinolytic activity and postoperative deep-vein thrombosis. Lancet (1974) 1.39
An objective study of alternative methods of heparin administration. Thromb Res (1980) 1.38
Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study. Diabetes Care (1998) 1.38
Efficacy of low-dose heparin in prevention of extensive deep-vein thrombosis in patients undergoing total-hip replacement. Lancet (1976) 1.38
Review of present status of prophylaxis of venous thromboembolism. Proc R Soc Med (1974) 1.37
Myocardial infarction and deep-vein thrombosis. Br Med J (1971) 1.33
The use of venous pressure measurements and directional doppler recordings in distinguishing between superficial and deep valvular incompetence in patients with deep venous insufficiency. Br J Surg (1973) 1.30
Acquired dysfibrinogenaemia in acute and chronic liver disease. Br J Haematol (1977) 1.30
Blood viscosity, red-cell flexibility, haematocrit, and plasma-fibrinogen in patients with angina. Lancet (1977) 1.29
Plasma exchange and platelet function in Raynaud's phenomenon. Thromb Res (1981) 1.28
Endotoxaemia and renal failure in cirrhosis and obstructive jaundice. Br Med J (1976) 1.25
Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study(1)). Atherosclerosis (2001) 1.25
The changing pattern of venous thromboembolic disease. Haemostasis (1997) 1.23
Measurement of the ultrasonic intima-media complex thickness in normal subjects. J Vasc Surg (1993) 1.22
Superficial thrombophlebitis of the legs: a randomized, controlled, follow-up study. Angiology (1999) 1.21
Graduated, static, external compression of the lower limb: a physiological assessment. Br J Surg (1980) 1.18
Deep vein thrombosis after elective knee surgery. An incidence study in 312 patients. J Bone Joint Surg Br (1989) 1.18
Deep-vein thrombosis in patients with fractures of the femoral neck. Br J Surg (1972) 1.18
Flavonoids. A review of the pharmacology and therapeutic efficacy of Daflon 500 mg in patients with chronic venous insufficiency and related disorders. Angiology (1994) 1.18
beta-thromboglobulin and platelet factor 4 levels in retinal vein occlusion. Br J Ophthalmol (1983) 1.16
Low-molecular-weight heparin and prevention of postoperative deep vein thrombosis. Br Med J (Clin Res Ed) (1982) 1.16
Reproducibility of computer-quantified carotid plaque echogenicity: can we overcome the subjectivity? Stroke (2000) 1.14
The value of Doppler blood velocity tracings in the detection of aortoiliac disease in patients with intermittent claudication. Surgery (1976) 1.13
The carotid intima-media thickness as a marker of the presence of severe symptomatic coronary artery disease. Eur Heart J (1994) 1.12
Screening for chronic cerebrospinal venous insufficiency (CCSVI) using ultrasound--recommendations for a protocol. Int Angiol (2011) 1.12
Somatic spectrum of cancer-associated single basepair substitutions in the TP53 gene is determined mainly by endogenous mechanisms of mutation and by selection. Hum Mutat (1995) 1.12
Tissue factor pathway inhibitor in endothelial cells colocalizes with glycolipid microdomains/caveolae. Regulatory mechanism(s) of the anticoagulant properties of the endothelium. Arterioscler Thromb Vasc Biol (1997) 1.11
The problems of thrombosis in the deep veins of the leg. Ann R Coll Surg Engl (1969) 1.11
Plasminogen activator expression in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol (1995) 1.11
Detection of deep vein thrombosis: survey and current status. Prog Cardiovasc Dis (1975) 1.11
Treatment of deep-vein thrombosis with streptokinase. Br J Surg (1969) 1.10
Femoral vein thrombosis and total hip replacement. Br Med J (1977) 1.10
The I 125 -labeled fibrinogen test and phlebography in the diagnosis of deep vein thrombosis. Milbank Mem Fund Q (1972) 1.09
Plasma heparin levels after administration of calcium and sodium salts of heparin. Thromb Res (1976) 1.09
Venous thromboembolism from air travel: the LONFLIT study. Angiology (2001) 1.08
The current status of low-dose heparin in the prophylaxis of thrombophlebitis and pulmonary embolism. World J Surg (1978) 1.08
Deep vein thrombosis. Detection and prevention. Circulation (1975) 1.08
The cephalic vein as a peripheral vascular graft. Surg Gynecol Obstet (1969) 1.07
Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels. Arterioscler Thromb Vasc Biol (2000) 1.07
Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence. Int Angiol (2005) 1.06
Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture. Arterioscler Thromb Vasc Biol (1999) 1.06
Venous wall function in the pathogenesis of varicose veins. Surgery (1992) 1.06